In certain groups of men, glucose-6-phosphate dehydrogenase (G6PD) deficiency was linked with an increased likelihood of severe COVID-19, a Veterans Affairs cohort study found. In Black men under 65, ...
A Chiesi Farmaceutici drug for a rare enzyme deficiency is now approved by the FDA, making it the first U.S. treatment for a disorder that leads to a range of cognitive and muscle problems. The ...
DURHAM, N.C. – Many people who undergo treatment for hepatitis C develop hemolytic anemia, a disorder that destroys red blood cells. In some cases, it is so severe they have to reduce their medication ...
An ultra-rare enzyme deficiency that keeps infants from achieving proper muscle function among other developmental delays now has its first FDA-approved treatment. The new product, a gene therapy ...
FDA approves avalglucosidase alfa-ngpt (Nexviazyme) for the treatment of patients 1 year and older with late-onset Pompe disease. FDA announced yesterday the approval of avalglucosidase alfa-ngpt, ...
Do you have IBS-like flare-ups after eating sweets made with regular white sugar, starches, and other foods like oranges, bananas, and cantaloupe (when these are low FODMAP choices)? You may need to ...
A young woman treated for suspected methaemoglobinaemia instead experiences worsening haemolysis that reveals a previously ...
Wellbeing Magazine on MSN
The enzymatic gap: Why your gut might be missing the right tools for digestion
If you've been struggling with bloating, gas, or cramping after meals and have gone down the rabbit hole of low-FODMAP diets ...
Sanfilippo syndrome, or mucopolysaccharidosis type III (MPS III), is a rare neurodegenerative disease that first appears in early childhood. There are four subtypes of Sanfilippo syndrome: A, B, C, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback